유전체학 서비스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Genomics Services Market size is expected to reach USD 27.14 Billion in 2034 from USD 10.06 Billion (2025) growing at a CAGR of 11.66% during 2026-2034.

The global genomics services market is experiencing rapid growth due to increasing applications of genomic technologies in healthcare, biotechnology, and research. Genomics services include DNA sequencing, gene expression analysis, bioinformatics services, and genetic testing. These services are widely used in disease diagnosis, personalized medicine, drug discovery, and agricultural research. The growing focus on precision medicine is significantly contributing to the expansion of the genomics services market.

Advancements in sequencing technologies and decreasing costs of genomic analysis are major drivers supporting market growth. Researchers and healthcare providers are increasingly using genomic data to understand disease mechanisms and develop targeted therapies. Additionally, increasing investments in biotechnology research and government support for genomic studies are accelerating the adoption of genomics services globally.

Looking forward, the genomics services market is expected to expand as genomic technologies become more integrated into clinical and research applications. The development of advanced bioinformatics tools and high-throughput sequencing platforms will enhance data analysis capabilities. Furthermore, the growing demand for personalized healthcare and early disease detection will continue to drive the adoption of genomics services worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service Type

• Next Generation Sequencing
• Genotyping
• Microarray
• Sanger Sequencing
• Other Services

By Application

• Research
• Diagnostics

By End Use

• Research Institutes
• Diagnostic Centers
• Pharmaceutical and Biotechnological Companies
• Contract Research Organizations (CROs)
• Other End Use

COMPANIES PROFILED

• 23andMe, Agilent Technologies, BGI Genomics, Bio Rad Laboratories, Color Genomics, Danaher, Eurofins Scientific, F HoffmannLa Roche, GE Healthcare, GENEWIZ Azenta, Illumina, LGC, Macrogen, IQVIA, QIAGEN
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENOMICS SERVICES MARKET: BY SERVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Service Type
• 4.2. Next Generation Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Genotyping Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Microarray Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sanger Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENOMICS SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENOMICS SERVICES MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmaceutical and Biotechnological Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Contract Research Organizations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other End Use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENOMICS SERVICES MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Service Type
  • 7.2.2 By Application
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Service Type
  • 7.3.2 By Application
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Service Type
  • 7.4.2 By Application
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Service Type
  • 7.5.2 By Application
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Service Type
  • 7.6.2 By Application
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL GENOMICS SERVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 23andMe
  • 9.2.2 Agilent Technologies
  • 9.2.3 BGI Genomics
  • 9.2.4 Bio Rad Laboratories
  • 9.2.5 Color Genomics
  • 9.2.6 Danaher
  • 9.2.7 Eurofins Scientific
  • 9.2.8 F. Hoffmann-La Roche
  • 9.2.9 GE Healthcare
  • 9.2.10 GENEWIZ (Azenta)
  • 9.2.11 Illumina
  • 9.2.12 LGC
  • 9.2.13 Macrogen
  • 9.2.14 IQVIA
  • 9.2.15 QIAGEN